InvestorsHub Logo
Followers 0
Posts 2177
Boards Moderated 0
Alias Born 04/13/2018

Re: Midasbro post# 116676

Tuesday, 09/15/2020 9:59:57 AM

Tuesday, September 15, 2020 9:59:57 AM

Post# of 232969
You mean the same HGEN that was Kaliobios. Same HGEN that just did a 5 to 1 Reverse Split. The same HGEN that has yet to publish any efficacy results and got forced into an extended P3.

The same company that still does not have an approved drug. Burns through 30 million a year and only has 40 million cash on hand this year?

Thanks but I will take an organic uplisting, preserve shareholder equity and a drug that didn't shift from mortality to decreasing hospital stays. CYDY will save lives, HGEN is just promoting a Remdesivir knock off.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News